Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biostage Inc (OTCQB:BSTG)

0.078
Delayed Data
As of Oct 19
 +0.0105 / +15.56%
Today’s Change
0.05
Today|||52-Week Range
1.42
-91.24%
Year-to-Date
No recent news for Biostage Inc.

Today’s Trading

Previous close0.07
Today’s open0.07
Day’s range0.05 - 0.08
Volume2,007,660
Average volume (3 months)1,496,952
Market cap$2.6M
Dividend yield--
Data as of 3:56pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)+30.48%
Earnings growth (this year)+42.47%
Earnings growth (next 5 years)--
Revenue growth (last year)-30.51%
P/E ratioNM
Price/Sales173.34
Price/Book0.65

Competitors

 Today’s
change
Today’s
% change
AMDAAmedica Corp+0.01+3.54%
--Suda Ltd0.000.00%
CYTXCytori Therapeutics ...-0.02-4.32%
AEMDAethlon Medical Inc0.000.00%
Data as of 3:59pm ET, 10/19/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$82.0K
Annual profit (last year)-$11.6M
Net profit margin-14,120.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Independent Director
James J. McGorry
Director-Quality &
Operations
Ginger A. Abraham-Freel
Corporate headquarters
Holliston, Massachusetts

Forecasts